Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
about
Translating Treg Therapy in Humanized MiceConcise review: humanized models of tumor immunology in the 21st century: convergence of cancer research and tissue engineeringT-Regulatory Cells and Vaccination "Pay Attention and Do Not Neglect Them": Lessons from HIV and Cancer Vaccine TrialsSingle-cell tracking of flavivirus RNA uncovers species-specific interactions with the immune system dictating disease outcomeConserved and divergent aspects of human T-cell development and migration in humanized miceCurrent advances in humanized mouse models.Long-term leukocyte reconstitution in NSG mice transplanted with human cord blood hematopoietic stem and progenitor cells.Engineering humanized mice for improved hematopoietic reconstitution.Human hemato-lymphoid system mice: current use and future potential for medicine.Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies.Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.HIV-1 Vpr accelerates viral replication during acute infection by exploitation of proliferating CD4+ T cells in vivoAn AAV vector-mediated gene delivery approach facilitates reconstitution of functional human CD8+ T cells in miceUse of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory DiseasesEngraftment of human HSCs in nonirradiated newborn NOD-scid IL2rγ null mice is enhanced by transgenic expression of membrane-bound human SCF.Life in the fast lane: mammalian disease models in the genomics era.Forced expression of human macrophage colony-stimulating factor in CD34+ cells promotes monocyte differentiation in vitro and in vivo but blunts osteoclastogenesis in vitro.Increasing hematopoietic stem cell yield to develop mice with human immune systems.Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantationCharacterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system miceHumanized mouse models of HIV infectionHumanized mice for immune system investigation: progress, promise and challengesCan humanized mice reflect the complex pathobiology of HIV-associated neurocognitive disorders?HIV therapy by a combination of broadly neutralizing antibodies in humanized mice.A xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti-IL-6R treatment.Improved B cell development in humanized NOD-scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testingSCLLTargeting FGFR1 to suppress leukemogenesis in syndromic and de novo AML in murine models.HIV-1 immunopathogenesis in humanized mouse models.Preclinical approaches in chronic myeloid leukemia: from cells to systemsCrimean-Congo Hemorrhagic Fever in Humanized Mice Reveals Glial Cells as Primary Targets of Neurological Infection.Vitamin D receptor activation reduces VCaP xenograft tumor growth and counteracts ERG activity despite induction of TMPRSS2:ERG.Ebola Virus Replication and Disease Without Immunopathology in Mice Expressing Transgenes to Support Human Myeloid and Lymphoid Cell Engraftment.Development of Humanized Mice in the Age of Genome Editing.Improving vaccine efficacy against malignant gliomaModeling Natural Killer Cell Targeted Immunotherapies.A germline-competent embryonic stem cell line from NOD.Cg-Prkdc ( scid ) Il2rg ( tm1Wjl )/SzJ (NSG) mice.Humanized mouse models: Application to human diseases.Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias.
P2860
Q26772335-A71987D1-9D15-4507-9C78-CD3850D02A65Q27022477-126868AA-D461-439A-A1A6-A20AD3BD9369Q28074437-C81FAB1C-36BA-4CB7-A170-D704983A9A3EQ28950496-C7106A66-49E8-4583-8F17-75D6A2B19224Q30664978-61D68F9C-CE4B-4E30-8A94-BFBB3EDF4C33Q33577361-92A6CB5B-4A13-4768-A276-79FD7F6CA185Q33742461-4CDE6204-AB6B-4F5C-8E21-1702D2594356Q33844310-1E0CEC96-342D-4115-BC3C-D25AC696CD3DQ33995307-3EA2B4C6-49DD-4CDD-BFC9-7C65E6DE2DF2Q34043004-9369E21F-5875-4760-B563-9626BC157E7BQ34223991-AE05B9F9-88CD-4F30-8953-0E42EC4E8107Q34474320-32D5986E-D535-47E4-A035-26AE232971F3Q35067233-A1203710-720D-4D1E-958A-437E00E2CAB5Q35091621-E6B4678E-1392-44B9-8FFB-715240119831Q35738486-2D4BB90A-DC93-4D0E-94D4-9482BB20D181Q35891607-262AECE8-1A72-4F08-BC61-CE94E3B96902Q36135110-EB8B6705-A648-478C-8ED1-38F8E08642A1Q36270576-67718A25-FAFC-4D7B-9AC3-5757499DCD3CQ36651190-E86DB142-EE20-4523-8175-2EAA7375DCA9Q36879075-E2D0F2C1-BBCA-4F75-8F8D-5B0FEE4C13D7Q37076201-85F69BF3-B98D-4952-9AD1-7F9CE3E610A2Q37089865-CABDE46B-E13A-47D7-9BE1-3FDF32625B2CQ37111994-C8936E5B-A678-4AE1-858C-11E87F61338AQ37195155-BFE5F4B5-CDCB-4FAB-B83D-1B7E8525C384Q37259407-21ED65DD-B28B-4AA7-8117-927D2197982DQ37277020-F5636F80-D61B-4EF6-A25A-FD5632A8EBC9Q37467601-E1186F2F-739E-43D1-B355-1495BE1246AAQ37547052-F950972D-AA2E-4271-82F2-B646A2205716Q37580305-39A6E7DA-F9B2-44E1-B040-D5EA702BF70DQ37676228-1776C9E1-D459-4A62-8FDD-96138823C72BQ37676954-9CD3762A-8A08-4B7B-ACCD-D81631905B86Q38686512-C3CF02B8-DA2F-428B-BD52-8A8337E49E8CQ38700950-207F8BE3-5327-4A3C-9A40-17B581B9F411Q38823792-FEBCB547-71D5-4262-ADC4-B53B7FEB1192Q38884521-E0C1C76C-A605-4F87-BD04-DCB29F663E58Q38953024-AB4819AB-6E7A-4B8F-8D56-32D5857C5A7DQ39239278-08A894E1-857A-404F-8F59-F7D0B3C239DEQ39319049-B151B56E-6CF5-48EF-9065-BD7AEB1C69FBQ39362145-C5F758F7-1B07-4E70-8D9F-197F5F0ED84EQ39642260-77F5EA08-D00C-4137-8088-7C251E69A583
P2860
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@ast
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@en
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@nl
type
label
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@ast
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@en
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@nl
prefLabel
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@ast
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@en
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@nl
P2093
P2860
P1433
P1476
Development of human CD4+FoxP3 ...... ID IL2Rγ(null) humanized mice.
@en
P2093
Alexander Ploss
Charles M Rice
Eva Billerbeck
Walter T Barry
P2860
P304
P356
10.1182/BLOOD-2010-08-301507
P407
P577
2011-01-20T00:00:00Z